Screener
Rhythm Pharmaceuticals, Inc. RYTM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total assets | $442,316 | $480,196 |
| Liabilities, Convertible Preferred Stock and Stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,299 | $13,947 |
| Accrued expenses and other current liabilities | 80,045 | 83,855 |
| Lease liability | 676 | 650 |
| Deferred revenue | 48 | 194 |
| Deferred royalty obligation, current | 10,130 | 7,296 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s accounts payable?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported accounts payable of $12.3M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s accounts payable increased by 3.2% year-over-year, from $11.91M to $12.3M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s accounts payable has grown at a 23.3% compound annual growth rate (CAGR), from $4.9M to $13.95M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude